Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy

Affiliations

• ¹ Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
• ² Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
• ³ CIBERONC, Instituto Carlos III, Madrid, Spain.
• ⁴ Hematology Department, Saint-Louis Hospital AP-HP, Paris, France.
• ⁵ Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
• ⁶ Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
• ⁷ Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.
• ⁸ Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
• ⁹ Indiana University Simon Cancer Center, Indianapolis, IN, USA.
• ¹⁰ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
• ¹¹ University of Illinois Cancer Center, Chicago, IL, USA.
• ¹² Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY, USA.
• ¹³ CHU of Nice, Hematology Department, Cote d'Azur University, Nice, France.
• ¹⁴ University of North Carolina Physician Network, Rocky Mount, NC, USA.
• ¹⁵ University Clinical Hospital, INCLIVA, Valencia, Spain.